Insights

European launch Nordic Pharma recently announced the European launch of Lacrifill for dry eye disease following CE mark approval, indicating a growing regional commercialization footprint and potential cross-border selling opportunities across Europe.

Mergers and growth The 2023 merger integrating Draupnir Bio ApS and Altacor/ParaPharm/Transdermal under Nordic Pharma signals a broadened product portfolio and enhanced R&D-to-market capabilities that can be leveraged to identify complementary client partnerships and co-marketing arrangements.

Biotech focus With emphasis on biotechnology derived medicines and sterile manufacturing, there is a clear avenue to target biopharma partners seeking contract manufacturing, early access programs, or licensing opportunities for advanced therapies.

Moderate revenue Revenue range of 10 to 25 million with a lean employee base (11-50) suggests a nimble organization that may respond quickly to pilot projects, value-based pricing discussions, and scalable manufacturing partnerships.

European access As a subsidiary of Nordic Group B.V. and active in European markets, there is potential to engage distributors, CROs, or hospital networks across Europe to accelerate Lacrifill adoption, while exploring parallel opportunities in adjacent therapeutics.

Similar companies to Nordic Pharma, Inc.

Nordic Pharma, Inc. Tech Stack

Nordic Pharma, Inc. uses 8 technology products and services including WordPress, jQuery, PWA, and more. Explore Nordic Pharma, Inc.'s tech stack below.

  • Content Management System
  • jQuery
    Javascript Libraries
  • PWA
    Miscellaneous
  • Priority Hints
    Performance
  • Platform As A Service
  • Google Tag Manager
    Tag Management
  • HTTP/3
    Web & Portal Technology
  • GoDaddy
    Web Hosting

Nordic Pharma, Inc.'s Email Address Formats

Nordic Pharma, Inc. uses at least 6 email formats:
Nordic Pharma, Inc. Email FormatsExamplePercentage
First.Last@amringpharma.comJohn.Doe@amringpharma.com
76%
Last@amringpharma.comDoe@amringpharma.com
24%
First.Last@amringusa.comJohn.Doe@amringusa.com
80%
LastF@amringusa.comDoeJ@amringusa.com
7%
First@amringusa.comJohn@amringusa.com
6%
FirstLast@amringusa.comJohnDoe@amringusa.com
7%

Frequently Asked Questions

What is Nordic Pharma, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Nordic Pharma, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nordic Pharma, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Nordic Pharma, Inc.'s official website is nordicpharmausa.com and has social profiles on LinkedIn.

How much revenue does Nordic Pharma, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Nordic Pharma, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Nordic Pharma, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Nordic Pharma, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Nordic Pharma, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Nordic Pharma, Inc. has approximately 19 employees across 3 continents, including North America, Europe and Africa. Key team members include Global Marketing And Launch Excellence Director: S. B., Financial Director: C. F. and Office Manager: M. M. Explore Nordic Pharma, Inc.'s employee directory with LeadIQ.

What industry does Nordic Pharma, Inc. belong to?

Minus sign iconPlus sign icon
Nordic Pharma, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Nordic Pharma, Inc. use?

Minus sign iconPlus sign icon
Nordic Pharma, Inc.'s tech stack includes WordPress, jQuery, PWA, Priority Hints, WP Engine, Google Tag Manager, HTTP/3 and GoDaddy.

What is Nordic Pharma, Inc.'s email format?

Minus sign iconPlus sign icon
Nordic Pharma, Inc.'s email format typically follows the pattern of First.Last@amringpharma.com. Find more Nordic Pharma, Inc. email formats with LeadIQ.

When was Nordic Pharma, Inc. founded?

Minus sign iconPlus sign icon
Nordic Pharma, Inc. was founded in 2014.
Nordic Pharma, Inc. logo

Nordic Pharma, Inc.

Pharmaceutical ManufacturingPennsylvania, United States11-50 Employees

Nordic Pharma, Inc. is a small- to mid-sized pharmaceutical manufacturer based in Berwyn, Pennsylvania. It operates as a subsidiary of Nordic Group B.V. and partners with established global biopharmaceutical companies to bring biotechnology-derived medicines and sterile manufacturing capabilities to the market. The company functions as a collaborative partner for biotechnology-focused products and related manufacturing services within the pharmaceutical sector.

Its customers are global biopharma firms seeking manufacturing and related technologies for biotech-derived therapies. The organization provides expertise in sterile production and other advanced manufacturing capabilities that support bringing such medicines to patients. A recent development noted is the European launch of Lacrifill, a therapy for dry eye disease, announced by the parent company Nordic Group, highlighting ongoing product activity in Europe.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $10M - $25M

    Nordic Pharma, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.